nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Pain in extremity—Epirubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Methylphenidate—Hot flush—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Methylphenidate—Increased appetite—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Methylphenidate—Migraine—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Methylphenidate—Affect lability—Epirubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Methylphenidate—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Methylphenidate—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Methylphenidate—Hypersensitivity—Sorafenib—thyroid cancer	0.00129	0.00129	CcSEcCtD
Methylphenidate—Asthenia—Sorafenib—thyroid cancer	0.00125	0.00125	CcSEcCtD
Methylphenidate—Cardiac arrest—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Methylphenidate—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Methylphenidate—Mood swings—Epirubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Methylphenidate—Lethargy—Doxorubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Methylphenidate—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Methylphenidate—Pruritus—Sorafenib—thyroid cancer	0.00124	0.00124	CcSEcCtD
Methylphenidate—Dehydration—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Methylphenidate—Diplopia—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Methylphenidate—Pain in extremity—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Methylphenidate—Liver function test abnormal—Epirubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Methylphenidate—Abdominal pain upper—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Methylphenidate—Migraine—Doxorubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Methylphenidate—Affect lability—Doxorubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Methylphenidate—Diarrhoea—Sorafenib—thyroid cancer	0.00119	0.00119	CcSEcCtD
Methylphenidate—Breast disorder—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Methylphenidate—Nasopharyngitis—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Methylphenidate—Gastritis—Epirubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Methylphenidate—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Methylphenidate—Cardiac arrest—Doxorubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Methylphenidate—Dizziness—Sorafenib—thyroid cancer	0.00115	0.00115	CcSEcCtD
Methylphenidate—Mood swings—Doxorubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Methylphenidate—Asthma—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Methylphenidate—Influenza—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Methylphenidate—Dehydration—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Methylphenidate—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Methylphenidate—Pancreatitis—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Methylphenidate—Vomiting—Sorafenib—thyroid cancer	0.00111	0.00111	CcSEcCtD
Methylphenidate—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Methylphenidate—Angina pectoris—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Methylphenidate—Rash—Sorafenib—thyroid cancer	0.0011	0.0011	CcSEcCtD
Methylphenidate—Dermatitis—Sorafenib—thyroid cancer	0.0011	0.0011	CcSEcCtD
Methylphenidate—Breast disorder—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Methylphenidate—Headache—Sorafenib—thyroid cancer	0.00109	0.00109	CcSEcCtD
Methylphenidate—Bronchitis—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Methylphenidate—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Methylphenidate—Pancytopenia—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Methylphenidate—Gastritis—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Methylphenidate—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Methylphenidate—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Methylphenidate—Asthma—Doxorubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Methylphenidate—Influenza—Doxorubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Methylphenidate—Nausea—Sorafenib—thyroid cancer	0.00104	0.00104	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Methylphenidate—Weight increased—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Methylphenidate—Pancreatitis—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Methylphenidate—Weight decreased—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Methylphenidate—Angina pectoris—Doxorubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Methylphenidate—Pneumonia—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Methylphenidate—Drowsiness—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Methylphenidate—Infestation—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Methylphenidate—Infestation NOS—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Methylphenidate—Bronchitis—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Methylphenidate—Pancytopenia—Doxorubicin—thyroid cancer	0.000997	0.000997	CcSEcCtD
Methylphenidate—Conjunctivitis—Epirubicin—thyroid cancer	0.000983	0.000983	CcSEcCtD
Methylphenidate—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000976	0.000976	CcSEcCtD
Methylphenidate—Sweating—Epirubicin—thyroid cancer	0.00097	0.00097	CcSEcCtD
Methylphenidate—Haematuria—Epirubicin—thyroid cancer	0.000964	0.000964	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000958	0.000958	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000957	0.000957	CcSEcCtD
Methylphenidate—Weight increased—Doxorubicin—thyroid cancer	0.000955	0.000955	CcSEcCtD
Methylphenidate—Epistaxis—Epirubicin—thyroid cancer	0.000954	0.000954	CcSEcCtD
Methylphenidate—Weight decreased—Doxorubicin—thyroid cancer	0.00095	0.00095	CcSEcCtD
Methylphenidate—Sinusitis—Epirubicin—thyroid cancer	0.000949	0.000949	CcSEcCtD
Methylphenidate—Pneumonia—Doxorubicin—thyroid cancer	0.000941	0.000941	CcSEcCtD
Methylphenidate—Infestation—Doxorubicin—thyroid cancer	0.000936	0.000936	CcSEcCtD
Methylphenidate—Infestation NOS—Doxorubicin—thyroid cancer	0.000936	0.000936	CcSEcCtD
Methylphenidate—Drowsiness—Doxorubicin—thyroid cancer	0.000936	0.000936	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000928	0.000928	CcSEcCtD
Methylphenidate—Bradycardia—Epirubicin—thyroid cancer	0.000924	0.000924	CcSEcCtD
Methylphenidate—Haemoglobin—Epirubicin—thyroid cancer	0.000913	0.000913	CcSEcCtD
Methylphenidate—Rhinitis—Epirubicin—thyroid cancer	0.00091	0.00091	CcSEcCtD
Methylphenidate—Conjunctivitis—Doxorubicin—thyroid cancer	0.00091	0.00091	CcSEcCtD
Methylphenidate—Haemorrhage—Epirubicin—thyroid cancer	0.000908	0.000908	CcSEcCtD
Methylphenidate—Pharyngitis—Epirubicin—thyroid cancer	0.000901	0.000901	CcSEcCtD
Methylphenidate—Sweating—Doxorubicin—thyroid cancer	0.000897	0.000897	CcSEcCtD
Methylphenidate—Urinary tract disorder—Epirubicin—thyroid cancer	0.000897	0.000897	CcSEcCtD
Methylphenidate—Haematuria—Doxorubicin—thyroid cancer	0.000892	0.000892	CcSEcCtD
Methylphenidate—Connective tissue disorder—Epirubicin—thyroid cancer	0.000892	0.000892	CcSEcCtD
Methylphenidate—Urethral disorder—Epirubicin—thyroid cancer	0.00089	0.00089	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000885	0.000885	CcSEcCtD
Methylphenidate—Epistaxis—Doxorubicin—thyroid cancer	0.000883	0.000883	CcSEcCtD
Methylphenidate—Sinusitis—Doxorubicin—thyroid cancer	0.000878	0.000878	CcSEcCtD
Methylphenidate—Visual impairment—Epirubicin—thyroid cancer	0.000875	0.000875	CcSEcCtD
Methylphenidate—Erythema multiforme—Epirubicin—thyroid cancer	0.000859	0.000859	CcSEcCtD
Methylphenidate—Bradycardia—Doxorubicin—thyroid cancer	0.000855	0.000855	CcSEcCtD
Methylphenidate—Eye disorder—Epirubicin—thyroid cancer	0.000849	0.000849	CcSEcCtD
Methylphenidate—Haemoglobin—Doxorubicin—thyroid cancer	0.000844	0.000844	CcSEcCtD
Methylphenidate—Flushing—Epirubicin—thyroid cancer	0.000843	0.000843	CcSEcCtD
Methylphenidate—Cardiac disorder—Epirubicin—thyroid cancer	0.000843	0.000843	CcSEcCtD
Methylphenidate—Rhinitis—Doxorubicin—thyroid cancer	0.000842	0.000842	CcSEcCtD
Methylphenidate—Haemorrhage—Doxorubicin—thyroid cancer	0.00084	0.00084	CcSEcCtD
Methylphenidate—Pharyngitis—Doxorubicin—thyroid cancer	0.000834	0.000834	CcSEcCtD
Methylphenidate—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00083	0.00083	CcSEcCtD
Methylphenidate—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000826	0.000826	CcSEcCtD
Methylphenidate—Angiopathy—Epirubicin—thyroid cancer	0.000824	0.000824	CcSEcCtD
Methylphenidate—Urethral disorder—Doxorubicin—thyroid cancer	0.000824	0.000824	CcSEcCtD
Methylphenidate—Immune system disorder—Epirubicin—thyroid cancer	0.00082	0.00082	CcSEcCtD
Methylphenidate—Mediastinal disorder—Epirubicin—thyroid cancer	0.000818	0.000818	CcSEcCtD
Methylphenidate—Chills—Epirubicin—thyroid cancer	0.000815	0.000815	CcSEcCtD
Methylphenidate—Arrhythmia—Epirubicin—thyroid cancer	0.000811	0.000811	CcSEcCtD
Methylphenidate—Visual impairment—Doxorubicin—thyroid cancer	0.00081	0.00081	CcSEcCtD
Methylphenidate—Alopecia—Epirubicin—thyroid cancer	0.000802	0.000802	CcSEcCtD
Methylphenidate—Mental disorder—Epirubicin—thyroid cancer	0.000796	0.000796	CcSEcCtD
Methylphenidate—Erythema multiforme—Doxorubicin—thyroid cancer	0.000794	0.000794	CcSEcCtD
Methylphenidate—Erythema—Epirubicin—thyroid cancer	0.00079	0.00079	CcSEcCtD
Methylphenidate—Malnutrition—Epirubicin—thyroid cancer	0.00079	0.00079	CcSEcCtD
Methylphenidate—Eye disorder—Doxorubicin—thyroid cancer	0.000785	0.000785	CcSEcCtD
Methylphenidate—Flushing—Doxorubicin—thyroid cancer	0.00078	0.00078	CcSEcCtD
Methylphenidate—Cardiac disorder—Doxorubicin—thyroid cancer	0.00078	0.00078	CcSEcCtD
Methylphenidate—Tension—Epirubicin—thyroid cancer	0.000776	0.000776	CcSEcCtD
Methylphenidate—Nervousness—Epirubicin—thyroid cancer	0.000768	0.000768	CcSEcCtD
Methylphenidate—Back pain—Epirubicin—thyroid cancer	0.000765	0.000765	CcSEcCtD
Methylphenidate—Angiopathy—Doxorubicin—thyroid cancer	0.000762	0.000762	CcSEcCtD
Methylphenidate—Muscle spasms—Epirubicin—thyroid cancer	0.00076	0.00076	CcSEcCtD
Methylphenidate—Immune system disorder—Doxorubicin—thyroid cancer	0.000759	0.000759	CcSEcCtD
Methylphenidate—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000757	0.000757	CcSEcCtD
Methylphenidate—Chills—Doxorubicin—thyroid cancer	0.000754	0.000754	CcSEcCtD
Methylphenidate—Arrhythmia—Doxorubicin—thyroid cancer	0.000751	0.000751	CcSEcCtD
Methylphenidate—Vision blurred—Epirubicin—thyroid cancer	0.000745	0.000745	CcSEcCtD
Methylphenidate—Alopecia—Doxorubicin—thyroid cancer	0.000742	0.000742	CcSEcCtD
Methylphenidate—Mental disorder—Doxorubicin—thyroid cancer	0.000736	0.000736	CcSEcCtD
Methylphenidate—Ill-defined disorder—Epirubicin—thyroid cancer	0.000733	0.000733	CcSEcCtD
Methylphenidate—Erythema—Doxorubicin—thyroid cancer	0.000731	0.000731	CcSEcCtD
Methylphenidate—Malnutrition—Doxorubicin—thyroid cancer	0.000731	0.000731	CcSEcCtD
Methylphenidate—Anaemia—Epirubicin—thyroid cancer	0.000731	0.000731	CcSEcCtD
Methylphenidate—Agitation—Epirubicin—thyroid cancer	0.000726	0.000726	CcSEcCtD
Methylphenidate—Tension—Doxorubicin—thyroid cancer	0.000718	0.000718	CcSEcCtD
Methylphenidate—Malaise—Epirubicin—thyroid cancer	0.000713	0.000713	CcSEcCtD
Methylphenidate—Nervousness—Doxorubicin—thyroid cancer	0.00071	0.00071	CcSEcCtD
Methylphenidate—Vertigo—Epirubicin—thyroid cancer	0.00071	0.00071	CcSEcCtD
Methylphenidate—Syncope—Epirubicin—thyroid cancer	0.000709	0.000709	CcSEcCtD
Methylphenidate—Leukopenia—Epirubicin—thyroid cancer	0.000708	0.000708	CcSEcCtD
Methylphenidate—Back pain—Doxorubicin—thyroid cancer	0.000708	0.000708	CcSEcCtD
Methylphenidate—Muscle spasms—Doxorubicin—thyroid cancer	0.000703	0.000703	CcSEcCtD
Methylphenidate—Palpitations—Epirubicin—thyroid cancer	0.000699	0.000699	CcSEcCtD
Methylphenidate—Loss of consciousness—Epirubicin—thyroid cancer	0.000695	0.000695	CcSEcCtD
Methylphenidate—Cough—Epirubicin—thyroid cancer	0.00069	0.00069	CcSEcCtD
Methylphenidate—Vision blurred—Doxorubicin—thyroid cancer	0.000689	0.000689	CcSEcCtD
Methylphenidate—Convulsion—Epirubicin—thyroid cancer	0.000685	0.000685	CcSEcCtD
Methylphenidate—Hypertension—Epirubicin—thyroid cancer	0.000682	0.000682	CcSEcCtD
Methylphenidate—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000679	0.000679	CcSEcCtD
Methylphenidate—Anaemia—Doxorubicin—thyroid cancer	0.000676	0.000676	CcSEcCtD
Methylphenidate—Arthralgia—Epirubicin—thyroid cancer	0.000673	0.000673	CcSEcCtD
Methylphenidate—Chest pain—Epirubicin—thyroid cancer	0.000673	0.000673	CcSEcCtD
Methylphenidate—Myalgia—Epirubicin—thyroid cancer	0.000673	0.000673	CcSEcCtD
Methylphenidate—Agitation—Doxorubicin—thyroid cancer	0.000672	0.000672	CcSEcCtD
Methylphenidate—Anxiety—Epirubicin—thyroid cancer	0.000671	0.000671	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000668	0.000668	CcSEcCtD
Methylphenidate—Discomfort—Epirubicin—thyroid cancer	0.000665	0.000665	CcSEcCtD
Methylphenidate—Malaise—Doxorubicin—thyroid cancer	0.00066	0.00066	CcSEcCtD
Methylphenidate—Dry mouth—Epirubicin—thyroid cancer	0.000658	0.000658	CcSEcCtD
Methylphenidate—Vertigo—Doxorubicin—thyroid cancer	0.000657	0.000657	CcSEcCtD
Methylphenidate—Syncope—Doxorubicin—thyroid cancer	0.000656	0.000656	CcSEcCtD
Methylphenidate—Leukopenia—Doxorubicin—thyroid cancer	0.000655	0.000655	CcSEcCtD
Methylphenidate—Confusional state—Epirubicin—thyroid cancer	0.000651	0.000651	CcSEcCtD
Methylphenidate—Palpitations—Doxorubicin—thyroid cancer	0.000646	0.000646	CcSEcCtD
Methylphenidate—Anaphylactic shock—Epirubicin—thyroid cancer	0.000645	0.000645	CcSEcCtD
Methylphenidate—Oedema—Epirubicin—thyroid cancer	0.000645	0.000645	CcSEcCtD
Methylphenidate—Loss of consciousness—Doxorubicin—thyroid cancer	0.000643	0.000643	CcSEcCtD
Methylphenidate—Infection—Epirubicin—thyroid cancer	0.000641	0.000641	CcSEcCtD
Methylphenidate—Cough—Doxorubicin—thyroid cancer	0.000638	0.000638	CcSEcCtD
Methylphenidate—Shock—Epirubicin—thyroid cancer	0.000635	0.000635	CcSEcCtD
Methylphenidate—Convulsion—Doxorubicin—thyroid cancer	0.000634	0.000634	CcSEcCtD
Methylphenidate—Nervous system disorder—Epirubicin—thyroid cancer	0.000633	0.000633	CcSEcCtD
Methylphenidate—Thrombocytopenia—Epirubicin—thyroid cancer	0.000632	0.000632	CcSEcCtD
Methylphenidate—Hypertension—Doxorubicin—thyroid cancer	0.000631	0.000631	CcSEcCtD
Methylphenidate—Tachycardia—Epirubicin—thyroid cancer	0.00063	0.00063	CcSEcCtD
Methylphenidate—Skin disorder—Epirubicin—thyroid cancer	0.000627	0.000627	CcSEcCtD
Methylphenidate—Hyperhidrosis—Epirubicin—thyroid cancer	0.000624	0.000624	CcSEcCtD
Methylphenidate—Myalgia—Doxorubicin—thyroid cancer	0.000623	0.000623	CcSEcCtD
Methylphenidate—Chest pain—Doxorubicin—thyroid cancer	0.000623	0.000623	CcSEcCtD
Methylphenidate—Arthralgia—Doxorubicin—thyroid cancer	0.000623	0.000623	CcSEcCtD
Methylphenidate—Anxiety—Doxorubicin—thyroid cancer	0.000621	0.000621	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000618	0.000618	CcSEcCtD
Methylphenidate—Discomfort—Doxorubicin—thyroid cancer	0.000615	0.000615	CcSEcCtD
Methylphenidate—Anorexia—Epirubicin—thyroid cancer	0.000615	0.000615	CcSEcCtD
Methylphenidate—Dry mouth—Doxorubicin—thyroid cancer	0.000609	0.000609	CcSEcCtD
Methylphenidate—Confusional state—Doxorubicin—thyroid cancer	0.000602	0.000602	CcSEcCtD
Methylphenidate—Oedema—Doxorubicin—thyroid cancer	0.000597	0.000597	CcSEcCtD
Methylphenidate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000597	0.000597	CcSEcCtD
Methylphenidate—Infection—Doxorubicin—thyroid cancer	0.000593	0.000593	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000588	0.000588	CcSEcCtD
Methylphenidate—Shock—Doxorubicin—thyroid cancer	0.000587	0.000587	CcSEcCtD
Methylphenidate—Nervous system disorder—Doxorubicin—thyroid cancer	0.000585	0.000585	CcSEcCtD
Methylphenidate—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000584	0.000584	CcSEcCtD
Methylphenidate—Insomnia—Epirubicin—thyroid cancer	0.000584	0.000584	CcSEcCtD
Methylphenidate—Tachycardia—Doxorubicin—thyroid cancer	0.000583	0.000583	CcSEcCtD
Methylphenidate—Skin disorder—Doxorubicin—thyroid cancer	0.00058	0.00058	CcSEcCtD
Methylphenidate—Paraesthesia—Epirubicin—thyroid cancer	0.000579	0.000579	CcSEcCtD
Methylphenidate—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000577	0.000577	CcSEcCtD
Methylphenidate—Dyspnoea—Epirubicin—thyroid cancer	0.000575	0.000575	CcSEcCtD
Methylphenidate—Somnolence—Epirubicin—thyroid cancer	0.000574	0.000574	CcSEcCtD
Methylphenidate—Anorexia—Doxorubicin—thyroid cancer	0.000569	0.000569	CcSEcCtD
Methylphenidate—Dyspepsia—Epirubicin—thyroid cancer	0.000568	0.000568	CcSEcCtD
Methylphenidate—Decreased appetite—Epirubicin—thyroid cancer	0.000561	0.000561	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000557	0.000557	CcSEcCtD
Methylphenidate—Fatigue—Epirubicin—thyroid cancer	0.000556	0.000556	CcSEcCtD
Methylphenidate—Pain—Epirubicin—thyroid cancer	0.000552	0.000552	CcSEcCtD
Methylphenidate—Constipation—Epirubicin—thyroid cancer	0.000552	0.000552	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000544	0.000544	CcSEcCtD
Methylphenidate—Insomnia—Doxorubicin—thyroid cancer	0.00054	0.00054	CcSEcCtD
Methylphenidate—Paraesthesia—Doxorubicin—thyroid cancer	0.000536	0.000536	CcSEcCtD
Methylphenidate—Dyspnoea—Doxorubicin—thyroid cancer	0.000532	0.000532	CcSEcCtD
Methylphenidate—Feeling abnormal—Epirubicin—thyroid cancer	0.000532	0.000532	CcSEcCtD
Methylphenidate—Somnolence—Doxorubicin—thyroid cancer	0.000531	0.000531	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000528	0.000528	CcSEcCtD
Methylphenidate—Dyspepsia—Doxorubicin—thyroid cancer	0.000525	0.000525	CcSEcCtD
Methylphenidate—Decreased appetite—Doxorubicin—thyroid cancer	0.000519	0.000519	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000515	0.000515	CcSEcCtD
Methylphenidate—Fatigue—Doxorubicin—thyroid cancer	0.000515	0.000515	CcSEcCtD
Methylphenidate—Urticaria—Epirubicin—thyroid cancer	0.000513	0.000513	CcSEcCtD
Methylphenidate—Constipation—Doxorubicin—thyroid cancer	0.00051	0.00051	CcSEcCtD
Methylphenidate—Pain—Doxorubicin—thyroid cancer	0.00051	0.00051	CcSEcCtD
Methylphenidate—Abdominal pain—Epirubicin—thyroid cancer	0.00051	0.00051	CcSEcCtD
Methylphenidate—Body temperature increased—Epirubicin—thyroid cancer	0.00051	0.00051	CcSEcCtD
Methylphenidate—Feeling abnormal—Doxorubicin—thyroid cancer	0.000492	0.000492	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000488	0.000488	CcSEcCtD
Methylphenidate—Hypersensitivity—Epirubicin—thyroid cancer	0.000475	0.000475	CcSEcCtD
Methylphenidate—Urticaria—Doxorubicin—thyroid cancer	0.000474	0.000474	CcSEcCtD
Methylphenidate—Body temperature increased—Doxorubicin—thyroid cancer	0.000472	0.000472	CcSEcCtD
Methylphenidate—Abdominal pain—Doxorubicin—thyroid cancer	0.000472	0.000472	CcSEcCtD
Methylphenidate—Asthenia—Epirubicin—thyroid cancer	0.000463	0.000463	CcSEcCtD
Methylphenidate—Pruritus—Epirubicin—thyroid cancer	0.000456	0.000456	CcSEcCtD
Methylphenidate—Diarrhoea—Epirubicin—thyroid cancer	0.000441	0.000441	CcSEcCtD
Methylphenidate—Hypersensitivity—Doxorubicin—thyroid cancer	0.00044	0.00044	CcSEcCtD
Methylphenidate—Asthenia—Doxorubicin—thyroid cancer	0.000428	0.000428	CcSEcCtD
Methylphenidate—Dizziness—Epirubicin—thyroid cancer	0.000427	0.000427	CcSEcCtD
Methylphenidate—Pruritus—Doxorubicin—thyroid cancer	0.000422	0.000422	CcSEcCtD
Methylphenidate—Vomiting—Epirubicin—thyroid cancer	0.00041	0.00041	CcSEcCtD
Methylphenidate—Diarrhoea—Doxorubicin—thyroid cancer	0.000408	0.000408	CcSEcCtD
Methylphenidate—Rash—Epirubicin—thyroid cancer	0.000407	0.000407	CcSEcCtD
Methylphenidate—Dermatitis—Epirubicin—thyroid cancer	0.000406	0.000406	CcSEcCtD
Methylphenidate—Headache—Epirubicin—thyroid cancer	0.000404	0.000404	CcSEcCtD
Methylphenidate—Dizziness—Doxorubicin—thyroid cancer	0.000395	0.000395	CcSEcCtD
Methylphenidate—Nausea—Epirubicin—thyroid cancer	0.000383	0.000383	CcSEcCtD
Methylphenidate—Vomiting—Doxorubicin—thyroid cancer	0.00038	0.00038	CcSEcCtD
Methylphenidate—Rash—Doxorubicin—thyroid cancer	0.000376	0.000376	CcSEcCtD
Methylphenidate—Dermatitis—Doxorubicin—thyroid cancer	0.000376	0.000376	CcSEcCtD
Methylphenidate—Headache—Doxorubicin—thyroid cancer	0.000374	0.000374	CcSEcCtD
Methylphenidate—Nausea—Doxorubicin—thyroid cancer	0.000355	0.000355	CcSEcCtD
